openPR Logo
Press release

Investigation announced for Investors who lost money with shares of QidelOrtho Corporation (NASDAQ: QDEL)

02-22-2024 07:02 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

An investigation for investors in QuidelOrtho Corporation (NASDAQ: QDEL) shares over potential securities laws violations.

An investigation for investors in QuidelOrtho Corporation (NASDAQ: QDEL) shares over potential securities laws violations.

An investigation was announced over potential securities laws violations by QuidelOrtho Corporation in connection with certain statements.

Investors who purchased shares of QuidelOrtho Corporation (NASDAQ: QDEL), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of QuidelOrtho Corporation (NASDAQ: QDEL) concerning whether a series of statements by QuidelOrtho Corporation regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

San Diego, CA based QuidelOrtho Corporation focuses on the development and manufacture of diagnostic testing technologies and solutions. QuidelOrtho Corporation reported that its annual Total Revenue rose from over $1.69 billion in 2021 to over $3.26 billion in 2022, and that its Net Income declined from $704.2 million in 2021 to $548.7 million in 2022.

On February 13, 2024, QuidelOrtho Corporation reported fourth quarter and full-year 2023 financial results. GAAP net income for Q4 2023 was $7 million, with diluted earnings per share (EPS) of $0.10, a decrease from $30.3 million and $0.45 EPS in the prior year period. Revenue for the quarter was $742.6M, missing estimates by $44.86M.

Then the Board of Directors terminated Douglas Bryant, President and CEO. Mr. Bryant has also resigned from the Board, both effective February 21, 2024.

Shares of QuidelOrtho Corporation (NASDAQ: QDEL) declined from $75.83 per share on December 22, 2023, to $41.75 per share on February 16, 2024.

Those who purchased shares of QuidelOrtho Corporation (NASDAQ: QDEL) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Investigation announced for Investors who lost money with shares of QidelOrtho Corporation (NASDAQ: QDEL) here

News-ID: 3395950 • Views:

More Releases from Shareholders Foundation

ALERT: Lawsuit filed for Investors who SOLD shares of Sina Corporation (formerly NASDAQ: SINA)
ALERT: Lawsuit filed for Investors who SOLD shares of Sina Corporation (formerly …
An investor, who sold shares of Sina Corporation (formerly NASDAQ: SINA) in the merger between Seina Corporation and TuSimple Holdings, Inc, filed a lawsuit over alleged violations of Federal Securities Laws by Sina Corporation (formerly NASDAQ: SINA in connection with certain allegedly false and misleading statements made. If you sold a significant amount of shares of Sina Corporation (formerly NASDAQ: SINA) between October 13, 2020 and March 22, 2021, you have
Lawsuit Alert: Investors who lost money with shares of Fluor Corporation (NYSE: FLR) should contact the Shareholders Foundation
Lawsuit Alert: Investors who lost money with shares of Fluor Corporation (NYSE: …
An investor, who purchased shares of Fluor Corporation (NYSE: FLR), filed a lawsuit alleged violations of Federal Securities Laws by Fluor Corporation in connection with certain allegedly false and misleading statements. Investors who purchased shares of Fluor Corporation (NYSE: FLR) have certain options and for certain investors are short and strict deadlines running. Deadline: November 14, 2025. NYSE: FLR investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779
Investigation announced for Long-Term Investors in shares of Sable Offshore Corp. (NYSE: SOC)
Investigation announced for Long-Term Investors in shares of Sable Offshore Corp …
An investigation was announced for long-term investors in shares of Sable Offshore Corp. (NYSE: SOC) concerning potential breaches of fiduciary duties by certain directors of Sable Offshore Corp. Investors who are current long term investors in Sable Offshore Corp. (NYSE: SOC) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in
Lawsuit filed for Investors who lost money with shares of Lantheus Holdings, Inc. (NASDAQ: LNTH)
Lawsuit filed for Investors who lost money with shares of Lantheus Holdings, Inc …
An investor, who purchased shares of Lantheus Holdings, Inc. (NASDAQ: LNTH), filed a lawsuit over alleged violations of Federal Securities Laws by Lantheus Holdings, Inc. in connection with certain allegedly false and misleading statements. Investors who purchased shares of Lantheus Holdings, Inc. (NASDAQ: LNTH) have certain options and for certain investors are short and strict deadlines running. Deadline: November 10, 2025. NASDAQ: LNTH investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com

All 5 Releases


More Releases for QuidelOrtho

Lyme Disease Diagnostics Market Poised for Growth Amid Rising Incidence Rates | …
Lyme Disease Diagnostics Market Overview Lyme Disease Diagnostics Market is projected to grow from USD 960 million in 2025 to USD 1.65 billion by 2032, registering a CAGR of 7.9%. The latest report (2025-2032) on the Lyme Disease Diagnostics Market by Coherent Market Insights offers an in-depth analysis of market trends, growth factors, challenges, and competition. It explores market size, revenue, production, consumption, and CAGR, using reliable research methods for accuracy. The
Arbovirus Testing Market Is Booming So Rapidly | DiaSorin, QuidelOrtho, NovaTec
The Global Arbovirus Testing Market Size is estimated at $1.4 Billion in 2025 and is forecast to register an annual growth rate (CAGR) of 4.6% to reach $2.1 Billion by 2034. The latest study released on the Global Arbovirus Testing Market by USD Analytics Market evaluates market size, trend, and forecast to 2034. The Arbovirus Testing market study covers significant research data and proofs to be a handy resource document for
Chemiluminescence Immunoassay Market Projected To Witness Substantial Growth, 20 …
Global chemiluminescence immunoassay market is estimated to be valued at USD 14.00 Bn in 2025 and is expected to reach USD 22.21 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 6.8% from 2025 to 2032. The Latest study titled Chemiluminescence Immunoassay Market 2025, published by Coherent Market Insights, provides valuable insights into both regional and global markets projected to grow in value from 2025 to 2032. The comprehensive
U.S. Blood Transfusion Diagnostics Market Size, Trends, Growth, Opportunities | …
The U.S. blood transfusion diagnostics market was valued at USD 1.91 billion in 2021 and is projected to grow from USD 2.20 billion in 2022 to USD 3.58 billion by 2029, recording a CAGR of 7.2% during the forecast period. The U.S. Blood Transfusion Diagnostics Market is witnessing remarkable growth, driven by advancements in diagnostic technologies, increasing demand for safe blood transfusions, and stringent regulatory standards. The market focuses on ensuring
Investigation announced for Investors in shares of QuidelOrtho Corporation (NASD …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of QuidelOrtho Corporation. Investors who are current long term investors in QuidelOrtho Corporation (NASDAQ: QDEL) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in NASDAQ: QDEL stocks follows a lawsuit filed against QuidelOrtho Corporation over
D dimer Testing Market Expecting Huge Demand in Upcoming Years |Siemens, QuidelO …
The latest study released on the Global D-dimer Testing Market by USD Analytics evaluates market size, trends, and forecast to 2032. The D-dimer Testing market study covers significant research data and proofs to be a handy resource document for managers, analysts, industry experts and other key people to have ready-to-access and self-analyzed study to help understand market trends, growth drivers, opportunities and upcoming challenges and about the competitors. Key Players in